Health

UK approves GlaxoSmithKline drug to treat COVID-19

British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it “retains activity” against the new Omicron variant.

For more coronavirus news, visit our dedicated page.

The monoclonal antibody “was found to be safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 infection who are at an increased risk of developing severe disease,” said the Medicines and Healthcare products Regulatory Agency (MHRA).

Moderna exec says company could have Omicron booster ready in March

Fauci: First US case of COVID-19 omicron variant identified

Health

New global action pledge to end TB by 2030

Applause rang out in one of the main conference rooms at UN headquarters on Friday as world leaders, civil society representatives and other stakeholders approved a declaration to advance efforts to end tuberculosis (TB) by 2030.

Health

World News in Brief: Peace day, high seas treaty, Palestinian displacement rises, polio in Ukraine

Peace requires strong mobilization for human rights, sustainable development and the environment, UN Secretary-General António Guterres said on the International Day of Peace observed on Thursday.